Skip to Main Content

Paper Details

Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 Patients.
Am J Respir Crit Care Med
7
2023
CF, CF lung disease, CF transmembrane conductance regulator, CFTR, Cystic Fibrosis Lung Disease, Lung disease, Patients, SNPs, chr11p13, chr5p13, cystic fibrosis, dysanapsis, genetic modifier loci, lung disease, pancreatic insufficiency, patients, persons, pulmonary disease, pwCF
Author NameAffiliation
Yi-Hui ZhouBioinformatics Research Center.
Yi-Hui Zhou
Paul J GallinsBioinformatics Research Center.
Elizabeth E BlueBrotman Baty Institute for Precision Medicine
Elizabeth E Blue
Elizabeth E BlueBrotman Baty Institute for Precision Medicine
Elizabeth E Blue
Kati J Buckingham
Kurt N HetrickCenter for Inherited Disease Research
Hua LingCenter for Inherited Disease Research
Kymberleigh A PagelThe Institute for Computational Medicine, The Johns Hopkins University
Yun Li
Yun LiUniversity of North Carolina at Chapel Hill
Yun Li
Yun Li
Yun Li
Yun LiUniversity of North Carolina at Chapel Hill
Michael J BamshadBrotman Baty Institute for Precision Medicine
Michael J BamshadUniversity of Washington
Michael J Bamshad
Michael J BamshadBrotman Baty Institute for Precision Medicine
Michael J Bamshad
Michael J BamshadUniversity of Washington
Garry R Cutting
Wanda K O'NealMarsico Lung Institute/UNC CF Research Center
Fred A WrightBioinformatics Research Center.
Fred A Wright
Fred A WrightNorth Carolina State University
  • 1 - 28

Datasets

Release 1.2